Industry: Service & Software
Published Date: 2025-02-20
Pages: 108 Pages
Report ld: 4024588
Request Sample
Customized Report
The global Pharmaceutical Cold Chain Management market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Pharmaceutical Cold Chain Management is a management of temperature-sensitive pharmaceutical products throughout their supply chain to ensure they are stored, transported, and distributed within specific temperature ranges to maintain efficacy and safety.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Pharmaceutical Cold Chain Management market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Cold Chain Management market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Pharmaceutical Cold Chain Management in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Pharmaceutical Cold Chain Management manufacturers competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by Type, by Application, revenue for each segment.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Cold Chain Management revenue, gross margin, and recent development, etc.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Self Management
1.2.3 Self Operated + Outsourcing
1.2.4 Outsourcing Three Parties
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Temperature-Sensitive Pharmaceuticals
1.3.3 Vaccines
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Cold Chain Management Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Pharmaceutical Cold Chain Management Revenue Market Share by Region (2020-2025)
2.4 Global Pharmaceutical Cold Chain Management Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Pharmaceutical Cold Chain Management Market Size and Prospective (2020-2031)
2.5.2 Europe Pharmaceutical Cold Chain Management Market Size and Prospective (2020-2031)
2.5.3 Asia-Pacific Pharmaceutical Cold Chain Management Market Size and Prospective (2020-2031)
2.5.4 Latin America Pharmaceutical Cold Chain Management Market Size and Prospective (2020-2031)
2.5.5 Middle East & Africa Pharmaceutical Cold Chain Management Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Pharmaceutical Cold Chain Management Historic Market Size by Type (2020-2025)
3.2 Global Pharmaceutical Cold Chain Management Forecasted Market Size by Type (2026-2031)
3.3 Different Types Pharmaceutical Cold Chain Management Representative Players
4 Breakdown Data by Application
4.1 Global Pharmaceutical Cold Chain Management Historic Market Size by Application (2020-2025)
4.2 Global Pharmaceutical Cold Chain Management Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Pharmaceutical Cold Chain Management Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Pharmaceutical Cold Chain Management Players by Revenue (2020-2025)
5.1.2 Global Pharmaceutical Cold Chain Management Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Pharmaceutical Cold Chain Management Revenue
5.4 Global Pharmaceutical Cold Chain Management Market Concentration Analysis
5.4.1 Global Pharmaceutical Cold Chain Management Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Cold Chain Management Revenue in 2024
5.5 Global Key Players of Pharmaceutical Cold Chain Management Head office and Area Served
5.6 Global Key Players of Pharmaceutical Cold Chain Management, Product and Application
5.7 Global Key Players of Pharmaceutical Cold Chain Management, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Pharmaceutical Cold Chain Management Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Pharmaceutical Cold Chain Management Market Size by Type (2020-2025)
6.1.2.2 North America Pharmaceutical Cold Chain Management Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Pharmaceutical Cold Chain Management Market Size by Application (2020-2025)
6.1.3.2 North America Pharmaceutical Cold Chain Management Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Pharmaceutical Cold Chain Management Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Pharmaceutical Cold Chain Management Market Size by Type (2020-2025)
6.2.2.2 Europe Pharmaceutical Cold Chain Management Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Pharmaceutical Cold Chain Management Market Size by Application (2020-2025)
6.2.3.2 Europe Pharmaceutical Cold Chain Management Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Asia-Pacific Market: Players, Segments and Downstream
6.3.1 Asia-Pacific Pharmaceutical Cold Chain Management Revenue by Company (2020-2025)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Pharmaceutical Cold Chain Management Market Size by Type (2020-2025)
6.3.2.2 Asia-Pacific Pharmaceutical Cold Chain Management Market Share by Type (2020-2025)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Pharmaceutical Cold Chain Management Market Size by Application (2020-2025)
6.3.3.2 Asia-Pacific Pharmaceutical Cold Chain Management Market Share by Application (2020-2025)
6.3.4 Asia-Pacific Market Trend and Opportunities
6.4 Latin America Market: Players, Segments and Downstream
6.4.1 Latin America Pharmaceutical Cold Chain Management Revenue by Company (2020-2025)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Pharmaceutical Cold Chain Management Market Size by Type (2020-2025)
6.4.2.2 Latin America Pharmaceutical Cold Chain Management Market Share by Type (2020-2025)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Pharmaceutical Cold Chain Management Market Size by Application (2020-2025)
6.4.3.2 Latin America Pharmaceutical Cold Chain Management Market Share by Application (2020-2025)
6.4.4 Latin America Market Trend and Opportunities
6.5 Middle East & Africa Market: Players, Segments and Downstream
6.5.1 Middle East & Africa Pharmaceutical Cold Chain Management Revenue by Company (2020-2025)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Pharmaceutical Cold Chain Management Market Size by Type (2020-2025)
6.5.2.2 Middle East & Africa Pharmaceutical Cold Chain Management Market Share by Type (2020-2025)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Pharmaceutical Cold Chain Management Market Size by Application (2020-2025)
6.5.3.2 Middle East & Africa Pharmaceutical Cold Chain Management Market Share by Application (2020-2025)
6.5.4 Middle East & Africa Market Trend and Opportunities
7 Key Players Profiles
7.1 Aeris Group
7.1.1 Aeris Group Company Details
7.1.2 Aeris Group Business Overview
7.1.3 Aeris Group Pharmaceutical Cold Chain Management Introduction
7.1.4 Aeris Group Revenue in Pharmaceutical Cold Chain Management Business (2020-2025)
7.1.5 Aeris Group Recent Development
7.2 American Aerogel Corporation
7.2.1 American Aerogel Corporation Company Details
7.2.2 American Aerogel Corporation Business Overview
7.2.3 American Aerogel Corporation Pharmaceutical Cold Chain Management Introduction
7.2.4 American Aerogel Corporation Revenue in Pharmaceutical Cold Chain Management Business (2020-2025)
7.2.5 American Aerogel Corporation Recent Development
7.3 Cold Chain Technologies
7.3.1 Cold Chain Technologies Company Details
7.3.2 Cold Chain Technologies Business Overview
7.3.3 Cold Chain Technologies Pharmaceutical Cold Chain Management Introduction
7.3.4 Cold Chain Technologies Revenue in Pharmaceutical Cold Chain Management Business (2020-2025)
7.3.5 Cold Chain Technologies Recent Development
7.4 Cryopak
7.4.1 Cryopak Company Details
7.4.2 Cryopak Business Overview
7.4.3 Cryopak Pharmaceutical Cold Chain Management Introduction
7.4.4 Cryopak Revenue in Pharmaceutical Cold Chain Management Business (2020-2025)
7.4.5 Cryopak Recent Development
7.5 CSafe
7.5.1 CSafe Company Details
7.5.2 CSafe Business Overview
7.5.3 CSafe Pharmaceutical Cold Chain Management Introduction
7.5.4 CSafe Revenue in Pharmaceutical Cold Chain Management Business (2020-2025)
7.5.5 CSafe Recent Development
7.6 DS Smith Pharma
7.6.1 DS Smith Pharma Company Details
7.6.2 DS Smith Pharma Business Overview
7.6.3 DS Smith Pharma Pharmaceutical Cold Chain Management Introduction
7.6.4 DS Smith Pharma Revenue in Pharmaceutical Cold Chain Management Business (2020-2025)
7.6.5 DS Smith Pharma Recent Development
7.7 EcoCool GmbH
7.7.1 EcoCool GmbH Company Details
7.7.2 EcoCool GmbH Business Overview
7.7.3 EcoCool GmbH Pharmaceutical Cold Chain Management Introduction
7.7.4 EcoCool GmbH Revenue in Pharmaceutical Cold Chain Management Business (2020-2025)
7.7.5 EcoCool GmbH Recent Development
7.8 Envirotainer
7.8.1 Envirotainer Company Details
7.8.2 Envirotainer Business Overview
7.8.3 Envirotainer Pharmaceutical Cold Chain Management Introduction
7.8.4 Envirotainer Revenue in Pharmaceutical Cold Chain Management Business (2020-2025)
7.8.5 Envirotainer Recent Development
7.9 Intelsius
7.9.1 Intelsius Company Details
7.9.2 Intelsius Business Overview
7.9.3 Intelsius Pharmaceutical Cold Chain Management Introduction
7.9.4 Intelsius Revenue in Pharmaceutical Cold Chain Management Business (2020-2025)
7.9.5 Intelsius Recent Development
7.10 Pelican Biothermal
7.10.1 Pelican Biothermal Company Details
7.10.2 Pelican Biothermal Business Overview
7.10.3 Pelican Biothermal Pharmaceutical Cold Chain Management Introduction
7.10.4 Pelican Biothermal Revenue in Pharmaceutical Cold Chain Management Business (2020-2025)
7.10.5 Pelican Biothermal Recent Development
7.11 Skycell
7.11.1 Skycell Company Details
7.11.2 Skycell Business Overview
7.11.3 Skycell Pharmaceutical Cold Chain Management Introduction
7.11.4 Skycell Revenue in Pharmaceutical Cold Chain Management Business (2020-2025)
7.11.5 Skycell Recent Development
7.12 Sofrigam SA Ltd.
7.12.1 Sofrigam SA Ltd. Company Details
7.12.2 Sofrigam SA Ltd. Business Overview
7.12.3 Sofrigam SA Ltd. Pharmaceutical Cold Chain Management Introduction
7.12.4 Sofrigam SA Ltd. Revenue in Pharmaceutical Cold Chain Management Business (2020-2025)
7.12.5 Sofrigam SA Ltd. Recent Development
7.13 Softbox Systems
7.13.1 Softbox Systems Company Details
7.13.2 Softbox Systems Business Overview
7.13.3 Softbox Systems Pharmaceutical Cold Chain Management Introduction
7.13.4 Softbox Systems Revenue in Pharmaceutical Cold Chain Management Business (2020-2025)
7.13.5 Softbox Systems Recent Development
7.14 Sonoco Products Company
7.14.1 Sonoco Products Company Company Details
7.14.2 Sonoco Products Company Business Overview
7.14.3 Sonoco Products Company Pharmaceutical Cold Chain Management Introduction
7.14.4 Sonoco Products Company Revenue in Pharmaceutical Cold Chain Management Business (2020-2025)
7.14.5 Sonoco Products Company Recent Development
7.15 Va-Q-tec AG
7.15.1 Va-Q-tec AG Company Details
7.15.2 Va-Q-tec AG Business Overview
7.15.3 Va-Q-tec AG Pharmaceutical Cold Chain Management Introduction
7.15.4 Va-Q-tec AG Revenue in Pharmaceutical Cold Chain Management Business (2020-2025)
7.15.5 Va-Q-tec AG Recent Development
7.16 World Courier
7.16.1 World Courier Company Details
7.16.2 World Courier Business Overview
7.16.3 World Courier Pharmaceutical Cold Chain Management Introduction
7.16.4 World Courier Revenue in Pharmaceutical Cold Chain Management Business (2020-2025)
7.16.5 World Courier Recent Development
7.17 ThemoFisher
7.17.1 ThemoFisher Company Details
7.17.2 ThemoFisher Business Overview
7.17.3 ThemoFisher Pharmaceutical Cold Chain Management Introduction
7.17.4 ThemoFisher Revenue in Pharmaceutical Cold Chain Management Business (2020-2025)
7.17.5 ThemoFisher Recent Development
8 Pharmaceutical Cold Chain Management Market Dynamics
8.1 Pharmaceutical Cold Chain Management Industry Trends
8.2 Pharmaceutical Cold Chain Management Market Drivers
8.3 Pharmaceutical Cold Chain Management Market Challenges
8.4 Pharmaceutical Cold Chain Management Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Pharmaceutical Cold Chain Management was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 130
USD 3950.00
(Single User License)
The global Pharmaceutical Cold Chain Management market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 123
USD 2900.00
(Single User License)
The global Pharmaceutical Cold Chain Management market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 148
USD 4900.00
(Single User License)
The global market for Pharmaceutical Cold Chain Management was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 137
USD 3950.00
(Single User License)
The global market for Pharmaceutical Cold Chain Management was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 99
USD 2900.00
(Single User License)
Pharmaceutical Cold Chain Management is a management of temperature-sensitive pharmaceutical products throughout their supply chain to ensure they are stored, transported, and distributed within specific temperature ranges to maintain efficacy and safety.
Published Date: 2024-04-08
Pages: 116
USD 4900.00
(Single User License)
Pharmaceutical Cold Chain Management is a management of temperature-sensitive pharmaceutical products throughout their supply chain to ensure they are stored, transported, and distributed within specific temperature ranges to maintain efficacy and safety.
Published Date: 2024-02-22
Pages: 133
USD 3950.00
(Single User License)
Pharmaceutical Cold Chain Management is a management of temperature-sensitive pharmaceutical products throughout their supply chain to ensure they are stored, transported, and distributed within specific temperature ranges to maintain efficacy and safety.
Published Date: 2024-01-17
Pages: 96
USD 2900.00
(Single User License)
The global market for Pharmaceutical Cold Chain Management was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 130
The global Pharmaceutical Cold Chain Management market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 123
The global Pharmaceutical Cold Chain Management market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 148
The global market for Pharmaceutical Cold Chain Management was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 137
The global market for Pharmaceutical Cold Chain Management was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 99
Pharmaceutical Cold Chain Management is a management of temperature-sensitive pharmaceutical products throughout their supply chain to ensure they are stored, transported, and distributed within specific temperature ranges to maintain efficacy and safety.
Published: 2024-04-08
Pages: 116
Pharmaceutical Cold Chain Management is a management of temperature-sensitive pharmaceutical products throughout their supply chain to ensure they are stored, transported, and distributed within specific temperature ranges to maintain efficacy and safety.
Published: 2024-02-22
Pages: 133
Pharmaceutical Cold Chain Management is a management of temperature-sensitive pharmaceutical products throughout their supply chain to ensure they are stored, transported, and distributed within specific temperature ranges to maintain efficacy and safety.
Published: 2024-01-17
Pages: 96
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now